FromLumistry ([email protected])
Sent withHubSpot
Subject (51)Med Intel w/ Michelle: FDA, Peptide & GLP-1 Updates
Preheader (150)Breaking down the latest FDA approvals, Medicare updates, & emerging compounded therapies. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Typography
Arial
Colors
Text Analysis
Body Words339
Subject Words9
Body Emojis1
Subject Emojis
Media Analysis
Text Links6
Image Links4
Total Links10
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px3443 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeMorning

Med Intel w/ Michelle: FDA, Peptide & GLP-1 Updates

Breaking down the latest FDA approvals, Medicare updates, & emerging compounded therapies. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Med Intel w/ Michelle: FDA, Peptide & GLP-1 Updates